Catalysis by entropic effects: the action of cytidine deaminase on 5,6-dihydrocytidine. 2002

Mark J Snider, and Danijela Lazarevic, and Richard Wolfenden
Department of Biochemistry & Biophysics and Department of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599-7260, USA.

In neutral solution, 5,6-dihydrocytidine undergoes spontaneous deamination (k25 approximately 3.2 x 10(-5) s(-1)) much more rapidly than does cytidine (k25 approximately 3.0 x 10(-10) s(-1)), with a more favorable enthalpy of activation (DeltaDeltaH# = -8.7 kcal/mol) compensated by a less favorable entropy of activation (TDeltaDeltaS# = -1.8 kcal/mol at 25 degrees C). E. coli cytidine deaminase enhances the rate of deamination of 5,6-dihydrocytidine (kcat/k(non) = 4.4 x 10(5)) by enhancing the entropy of activation (DeltaDeltaH# = 0 kcal/mol; TDeltaDeltaS# = +7.6 kcal/mol, at 25 degrees C). Binding of the competitive inhibitor 3,4,5,6-tetrahydrouridine (THU), a stable analogue of 5,6-dihydrocytidine in the transition state for its deamination, is accompanied by a release of enthalpy (DeltaH = -7.1 kcal/mol, TDeltaDeltaS = +2.2 kcal/mol) that approaches the estimated enthalpy of binding of the actual substrate in the transition state for deamination of 5,6-dihydrocytidine (DeltaH = -8.1 kcal/mol, TDeltaDeltaS = +6.0 kcal/mol). Thus, the shortcomings of THU in capturing all of the binding affinity expected of an ideal transition-state analogue reflect a less favorable entropy of association. That difference may arise from the analogue's inability to displace a water molecule from the "leaving group site" at which ammonia is generated in the normal reaction. The effect on binding of removing the 4-OH group from the transition-state analogue THU, to form 3,4,5,6-tetrahydrozebularine (THZ) (DeltaDeltaH = -2.1 kcal/mol, TDeltaDeltaS = -4.4 kcal/mol), is mainly entropic, consistent with the inability of THZ to displace water from the "attacking group site". These results are consistent with earlier indications [Snider, M. J., and Wolfenden, R. (2001) Biochemistry 40, 11364] that site-bound water plays a prominent role in substrate activation and inhibitor binding by cytidine deaminase.

UI MeSH Term Description Entries
D002384 Catalysis The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction. Catalyses
D003562 Cytidine A pyrimidine nucleoside that is composed of the base CYTOSINE linked to the five-carbon sugar D-RIBOSE. Cytosine Ribonucleoside,Cytosine Riboside,Ribonucleoside, Cytosine,Riboside, Cytosine
D003564 Cytidine Deaminase An enzyme that catalyzes the deamination of cytidine, forming uridine. EC 3.5.4.5. Cytidine Aminohydrolase,Aminohydrolase, Cytidine,Deaminase, Cytidine
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000588 Amines A group of compounds derived from ammonia by substituting organic radicals for the hydrogens. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amine
D019277 Entropy The measure of that part of the heat or energy of a system which is not available to perform work. Entropy increases in all natural (spontaneous and irreversible) processes. (From Dorland, 28th ed) Entropies

Related Publications

Mark J Snider, and Danijela Lazarevic, and Richard Wolfenden
February 1975, Biochemistry,
Mark J Snider, and Danijela Lazarevic, and Richard Wolfenden
April 1995, Biochemistry,
Mark J Snider, and Danijela Lazarevic, and Richard Wolfenden
January 2004, Cancer investigation,
Mark J Snider, and Danijela Lazarevic, and Richard Wolfenden
May 2009, PLoS pathogens,
Mark J Snider, and Danijela Lazarevic, and Richard Wolfenden
May 2007, Proceedings of the National Academy of Sciences of the United States of America,
Mark J Snider, and Danijela Lazarevic, and Richard Wolfenden
December 1996, Biochemistry,
Mark J Snider, and Danijela Lazarevic, and Richard Wolfenden
February 2009, Cancer chemotherapy and pharmacology,
Mark J Snider, and Danijela Lazarevic, and Richard Wolfenden
February 1996, Biochemistry,
Mark J Snider, and Danijela Lazarevic, and Richard Wolfenden
January 2006, Journal of chemical information and modeling,
Mark J Snider, and Danijela Lazarevic, and Richard Wolfenden
January 1987, Biomedical chromatography : BMC,
Copied contents to your clipboard!